Standard
Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding. / Mérie, Charlotte; Køber, Lars; Skov Olsen, Peter; Andersson, Charlotte; Gislason, Gunnar; Skov Jensen, Jan; Torp-Pedersen, Christian.
In:
J A M A: The Journal of the American Medical Association, Vol. 308, No. 20, 2012, p. 2118-25.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Mérie, C
, Køber, L, Skov Olsen, P, Andersson, C
, Gislason, G, Skov Jensen, J
& Torp-Pedersen, C 2012, '
Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding',
J A M A: The Journal of the American Medical Association, vol. 308, no. 20, pp. 2118-25.
https://doi.org/10.1001/jama.2012.54506APA
Mérie, C.
, Køber, L., Skov Olsen, P., Andersson, C.
, Gislason, G., Skov Jensen, J.
, & Torp-Pedersen, C. (2012).
Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding.
J A M A: The Journal of the American Medical Association,
308(20), 2118-25.
https://doi.org/10.1001/jama.2012.54506Vancouver
Mérie C
, Køber L, Skov Olsen P, Andersson C
, Gislason G, Skov Jensen J et al.
Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding.
J A M A: The Journal of the American Medical Association. 2012;308(20):2118-25.
https://doi.org/10.1001/jama.2012.54506Author
Mérie, Charlotte ; Køber, Lars ; Skov Olsen, Peter ; Andersson, Charlotte ; Gislason, Gunnar ; Skov Jensen, Jan ; Torp-Pedersen, Christian. / Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding. In: J A M A: The Journal of the American Medical Association. 2012 ; Vol. 308, No. 20. pp. 2118-25.
Bibtex
@article{5bd5a6836e7b4a71b70ea97f6ba71fe5,
title = "Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding",
abstract = "The need for anticoagulation after surgical aortic valve replacement (AVR) with biological prostheses is not well examined.",
author = "Charlotte M{\'e}rie and Lars K{\o}ber and {Skov Olsen}, Peter and Charlotte Andersson and Gunnar Gislason and {Skov Jensen}, Jan and Christian Torp-Pedersen",
year = "2012",
doi = "10.1001/jama.2012.54506",
language = "English",
volume = "308",
pages = "2118--25",
journal = "JAMA - Journal of the American Medical Association",
issn = "0098-7484",
publisher = "American Medical Association",
number = "20",
}
RIS
TY - JOUR
T1 - Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding
AU - Mérie, Charlotte
AU - Køber, Lars
AU - Skov Olsen, Peter
AU - Andersson, Charlotte
AU - Gislason, Gunnar
AU - Skov Jensen, Jan
AU - Torp-Pedersen, Christian
PY - 2012
Y1 - 2012
N2 - The need for anticoagulation after surgical aortic valve replacement (AVR) with biological prostheses is not well examined.
AB - The need for anticoagulation after surgical aortic valve replacement (AVR) with biological prostheses is not well examined.
U2 - 10.1001/jama.2012.54506
DO - 10.1001/jama.2012.54506
M3 - Journal article
C2 - 23188028
VL - 308
SP - 2118
EP - 2125
JO - JAMA - Journal of the American Medical Association
JF - JAMA - Journal of the American Medical Association
SN - 0098-7484
IS - 20
ER -
